A METHOD OF REDUCING THE "IN VIVO" CHOLESTEROL ESTER TRANSFER PROTEIN MEDIATED TRANSFER OF CHOLESTERYL ESTERS BETWEEN HIGH DENSITY LIPOPROTEINS (HDL) AND LOW DENSITY LIPOPROTEINS (LDL) - Patent 1432425

(19)

(11)

EP 1 432 425 A1

(12)

(43)	Date of publication:
	30.06.2004 Bulletin 2004/27

(21)	Application number: 02764428.5

(22)	Date of filing: 26.09.2002

(51)	International Patent Classification (IPC)⁷: A61K 31/575, A61P 3/06, A61P 9/10

(86)	International application number:
	PCT/CA2002/001457

(87)	International publication number:
	WO 2003/026672 (03.04.2003 Gazette 2003/14)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

26.09.2001 US 965687

(71)	Applicant: Forbes Medi-Tech Inc.
	Vancouver,British Columbia V6C 2T8 (CA)

(72)	Inventors:
	PRITCHARD, P., Haydn Vancouver, British Columbia V6N 2X6 (CA) WASAN, Kishor, M. Vancouver, British Columbia V4Z 5N2 (CA)

(74)	Representative: Jones, Helen Marjorie Meredith
	Gill Jennings & Every,Broadgate House,7 Eldon Street London EC2M 7LH London EC2M 7LH (GB)

(54)	A METHOD OF REDUCING THE "IN VIVO" CHOLESTEROL ESTER TRANSFER PROTEIN MEDIATED TRANSFER OF CHOLESTERYL ESTERS BETWEEN HIGH DENSITY LIPOPROTEINS (HDL) AND LOW DENSITY LIPOPROTEINS (LDL)